AUS
NZ
UK
CA
USA
IND
Healthcare
How (LSE:IXI) Is Expanding Its Role in Brain Imaging Innovation
July 07, 2026 12:37 PM BST| By Vivek SinghDiscover how IXICO (LSE:IXI) strengthened its business outlook through expanding client relationships, AI-powered neuroscience imaging solutions, and growing demand from pharmaceutical and biotechnology companies worldwide.
UK Healthcare Stocks In Focus As Defensive Healthcare Demand Meets A Selective London Market
July 07, 2026 09:17 AM BST| By Vivek SinghUK Healthcare Stocks are drawing attention as commodity swings, oil sensitivity and renewed attention on real assets changes how London investors read company updates, sector resilience and earnings quality.
What Is Putting Healthcare Stocks Back In Focus
July 07, 2026 09:15 AM BST| By Vivek SinghUK Healthcare Stocks are drawing attention as a softer services backdrop and a selective London tape changes how London investors read company updates, sector resilience and earnings quality.
Why Healthcare Stocks Are Back In Focus As London Investors Recheck Market Mood
July 06, 2026 03:38 PM BST| By Vivek SinghHighlights,Healthcare Stocks are active because healthcare shares are mixed as investors separate defensive medical demand from biotech funding risk and company-specific execution in diagnostics, devices, and therapeutics.,AstraZeneca (LSE:AZN), Conv...
Why Healthcare Stocks Are Back In Focus As London Investors Recheck Company News
July 06, 2026 03:38 PM BST| By Vivek SinghHighlights,Healthcare Stocks are active because healthcare shares are mixed as investors separate defensive medical demand from biotech funding risk and company-specific execution in diagnostics, devices, and therapeutics.,AstraZeneca (LSE:AZN), Conv...
Why Healthcare Stocks Are Back In Focus As London Investors Recheck Sector Rotation
July 06, 2026 03:38 PM BST| By Vivek SinghHighlights,Healthcare Stocks are active because healthcare shares are mixed as investors separate defensive medical demand from biotech funding risk and company-specific execution in diagnostics, devices, and therapeutics.,AstraZeneca (LSE:AZN), Conv...
Why AstraZeneca (LSE:AZN) Is Drawing Fresh Market Attention
July 06, 2026 01:21 PM BST| By Vivek SinghExplore why AstraZeneca (LSE:AZN) is attracting attention before its quarterly results, with a closer look at its drug pipeline, clinical developments, research strategy, and future growth initiatives.
Top ASX Healthcare Stocks: Why CSL (ASX:CSL) Is Surging
July 06, 2026 10:51 AM BST| By SamLarge-cap healthcare is returning to the spotlight as markets prioritise valuation repair, operational execution and sustainable global demand, placing Australia's leading healthcare companies under closer scrutiny during the new financial year.
Why Is Craneware (LSE:CRW) Facing Fresh Market Attention?
July 03, 2026 12:15 PM BST| By Vivek SinghExplore why Craneware (LSE:CRW) updated its annual outlook, how delayed revenue recognition influenced expectations, and what ongoing healthcare software demand could mean for the business.
Craneware (LSE:CRW) Eyes Future Growth Despite Revenue Setback
July 03, 2026 09:38 AM BST| By Vivek SinghExplore why Craneware (LSE:CRW) expects softer annual revenue, how deferred contracts affected performance, and what the company's long-term healthcare technology strategy means for its future.
The UK Market Theme Pulling Healthcare Stocks Back Into View
July 03, 2026 09:15 AM BST| By Vivek SinghUK healthcare stocks are in focus as healthcare is being treated as a defensive growth area while investors examine pipelines, regulation and global demand, with London investors weighing fresh market signals and company updates.
Why UK Healthcare Stocks Are In Focus As Defensive Growth Regains Attention
July 03, 2026 09:14 AM BST| By Vivek SinghUK healthcare stocks are in focus as healthcare is being treated as a defensive growth area while investors examine pipelines, regulation and global demand, with London investors weighing fresh market signals and company updates.
AstraZeneca’s (LSE:AZN) Valuation Puzzle Deepens as Cancer Pipeline Takes Centre Stage
July 03, 2026 07:18 AM BST| By Vivek SinghAstraZeneca’s valuation debate reflects a gap between market sentiment and long-term cash flow expectations, driven by oncology innovation, pipeline progress, and evolving pharmaceutical sector dynamics across global healthcare markets.
Why Is AstraZeneca (LSE:AZN) Drawing Fresh Attention Amid Valuation Debate?
July 03, 2026 06:53 AM BST| By Vivek SinghExplore why AstraZeneca (LSE:AZN) remains in focus as valuation discussions, healthcare innovation, and pipeline expansion continue shaping long-term market expectations.
`Why Is AstraZeneca (LSE:AZN) Strengthening Its Cancer Treatment Pipeline?
July 03, 2026 05:56 AM BST| By Vivek SinghDiscover how AstraZeneca is expanding its oncology portfolio through new European approvals, advanced lung cancer research, and precision medicine initiatives that continue shaping its long-term healthcare strategy.
Why Healthcare Stocks Are Back In The London Market Conversation As Defensive Healthcare Builds
July 03, 2026 12:19 AM BST| By Vivek SinghHighlights,Primary Health Properties (LSE:PHP) has put healthcare real estate back in focus after announcing debt refinancing, a reminder that funding access still matters for property-backed income names.,GSK (LSE:GSK), AstraZeneca (LSE:AZN) and Hal...
Why Healthcare Stocks Are Back In The London Market Conversation As Pipeline Scrutiny Builds
July 03, 2026 12:19 AM BST| By Vivek SinghHighlights,Primary Health Properties (LSE:PHP) has put healthcare real estate back in focus after announcing debt refinancing, a reminder that funding access still matters for property-backed income names.,GSK (LSE:GSK), AstraZeneca (LSE:AZN) and Hal...
What Is Driving Fresh Interest In Healthcare Stocks As London Turns Selective
July 03, 2026 12:19 AM BST| By Vivek SinghHighlights,Primary Health Properties (LSE:PHP) has put healthcare real estate back in focus after announcing debt refinancing, a reminder that funding access still matters for property-backed income names.,GSK (LSE:GSK), AstraZeneca (LSE:AZN) and Hal...
Best LSE Healthcare Stocks to Watch for July 2026
July 02, 2026 09:55 AM BST| By Vivek SinghGNS, ONT, OXB, IBT and BVXP represent diverse areas of healthcare innovation through biotechnology, diagnostics, genomics and advanced scientific research, highlighting the sector's continued evolution.
How Is Halma (LSE:HLMA) Strengthening Its Healthcare Business?
July 02, 2026 09:37 AM BST| By Vivek SinghHalma (LSE:HLMA) expands its healthcare portfolio through strategic acquisitions, strengthening medical software and cancer treatment technologies while supporting long-term innovation across European healthcare markets.
